Serum ghrelin levels in patients with Behcet's disease.
Postepy Dermatol Alergol 2016;
33:450-456. [PMID:
28035223 PMCID:
PMC5183784 DOI:
10.5114/ada.2016.63884]
[Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2015] [Accepted: 11/12/2015] [Indexed: 01/23/2023] Open
Abstract
Introduction
Behcet’s disease (BD) is a chronic, relapsing, systemic vasculitis of unknown etiology.
Aim
To measure serum ghrelin levels in BD patients and healthy controls and to investigate its association with metabolic syndrome (MetS).
Material and methods
Thirty BD patients and 30 healthy individuals were enrolled in the study. Ghrelin levels were measured in blood samples using ELISA.
Results
The mean serum ghrelin level in BD patients (28.57 ±14.04) was significantly lower compared to healthy controls (40.72 ±23.21) (p = 0.01). The mean serum ghrelin level in BD patients who had MetS (24.18 ±12.73) was lower compared to BD patients who did not have MetS (30.77 ±14.45), but this difference was not significant (p > 0.05).
Conclusions
Ghrelin levels were lower in BD patients compared to healthy controls. There was no association between reduced ghrelin levels and MetS; however, there was a negative correlation between ghrelin levels and disease activity.
Collapse